Jun 2, 2026 12:32PM
Apr 28, 2026 09:18AM
Apr 24, 2026 09:27AM
Apr 24, 2026 06:47AM
Apr 24, 2026 04:26AM
Apr 22, 2026 04:21PM
Mar 6, 2026 06:18AM Barclays Upgrades Medpace (MEDP) to Equalweight
Mar 3, 2026 02:18AM
Feb 18, 2026 07:12AM
Feb 13, 2026 01:08AM
Feb 11, 2026 08:53AM
Feb 11, 2026 05:20AM
Feb 10, 2026 04:09PM
Feb 10, 2026 03:59PM Medpace (MEDP) PT Lowered to $500 at Barclays
Feb 9, 2026 04:41PM
Feb 9, 2026 04:17PM
Oct 27, 2025 09:25AM
Oct 23, 2025 04:11PM
Oct 22, 2025 04:22PM
Oct 2, 2025 06:10AM
Sep 3, 2025 03:55AM Rothschild Redburn Downgrades Medpace (MEDP) to Neutral
Jul 29, 2025 03:50AM
Jul 23, 2025 07:03AM
Jul 22, 2025 03:04PM
Jul 22, 2025 09:58AM
Jul 21, 2025 04:18PM
Jun 24, 2025 06:16AM
Jun 6, 2025 07:47AM Truist Reiterates Hold Rating on Medpace (MEDP) Amid 'Choppy Macro'
Apr 22, 2025 10:07AM
Apr 22, 2025 09:26AM
Apr 21, 2025 04:19PM
Apr 14, 2025 05:30AM
Feb 10, 2025 04:20PM
Jan 21, 2025 10:36AM
Nov 25, 2024 07:36AM Medpace (MEDP) PT Raised to $354 at Baird
Oct 23, 2024 03:36AM
Oct 22, 2024 07:54AM
Oct 21, 2024 04:42PM
Oct 21, 2024 04:18PM
Oct 14, 2024 11:50AM
Sep 27, 2024 03:02AM
Sep 25, 2024 07:33AM Investors should cut exposure to CROs as biotech market slows: Jefferies
Sep 25, 2024 03:23AM
Aug 16, 2024 07:24AM
Aug 1, 2024 03:14AM
Jul 24, 2024 09:11AM
Jul 24, 2024 07:22AM
Jul 24, 2024 05:59AM
Jul 22, 2024 04:18PM Medpace Holdings (MEDP) Tops Q2 EPS by 22c, provides guidance
Jul 8, 2024 10:47AM

416,802 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All